Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD 0.0320
0.00 (0.00%)
Aug 27, 2026, 3:58 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 178.83 million as of August 27, 2026. Its market cap has increased by 6.67% in one year.
Market Cap
178.83M
Enterprise Value
239.44M
Revenue
914.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 178.83M, a decrease of -75.14%. That is a compound annual growth rate of -9.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 178.83M | 10.34% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fusen Pharmaceutical Company | 591.44M |
| Zhongzhi Pharmaceutical Holdings | 574.29M |
| China NT Pharma Group Company | 379.60M |
| Wai Yuen Tong Medicine Holdings | 334.31M |
| Regent Pacific Group | 259.72M |
| Tianda Pharmaceuticals | 238.65M |
| Extrawell Pharmaceutical Holdings | 232.00M |
| Shenzhen Neptunus Interlong Bio-technique Company | 189.61M |